Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, ...

Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug dis ...

Headlamp Health has launched Lumos AI®, a new decision-support platform designed to bring greater precision to neuroscience ...

InSilico Medicine Cayman TopCo, an artificial intelligence drug discovery startup, said on Monday that it has secured a ...

Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, ...

BenchSci, a disease biology generative AI platform, announced a three-year agreement with biopharmaceutical company Sanofi to deploy and use its Ascend platform throughout Sanofi's preclinical ...

Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Drug formulation technology ...

TEL AVIV, Israel--(BUSINESS WIRE)--QuantHealth, an AI-powered drug development platform, today announced the appointment of Sharon Dagan as Chief Architect and Siwar El Assad as Chief Information ...

RADNOR, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (CERT), a global leader in model-informed drug development, today announced the appointment of Christopher Bouton, Ph.D., as Chief ...

Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical's HLA-G targeted exosome program.  Shine-On ...